Whether you’re a Clinical Research Associate, a Project Manager, part of a Strategic team or work in another field, there’s a category for you in this year’s Clinical Researcher of the Year – The Americas.
Whether you’re a Clinical Research Associate, a Project Manager, part of a Strategic team or work in another field, there’s a category for you in this year’s Clinical Researcher of the Year – The Americas.
In its annual results briefing in Basel, Switzerland, Novartis emphasised the integration of digital and data into the way the company works, claiming to be spending ‘in the 100s of millions’ on collating its ‘goldmine’ of more than two million patient years of clinical trial data.
The National Institute for Health and Care Excellence (NICE) has approved Novartis’ chimeric antigen receptor T-cell (CAR T-cell) therapy Kymriah for treatment of adults with diffuse large B-cell lymphoma (DLBCL).
Male contraception is being put to the test in Manchester and Edinburgh, where couples are being invited to take part in a ground-breaking international study trialling a new form of male contraception.
MeiraGTx has announced a strategic collaboration with Johnson & Johnson’s Janssen to develop and commercialise gene therapy treatments for inherited retinal diseases (IRDs).
Coeliac UK has combined forces with Innovate UK to drive improvements worth £750,000 in the food technology, diagnostics and digital care industries to provide help for people who need to live gluten free.
A new digitally-enhanced service for people with heart failure is to be trialled in Greater Manchester, where around 1,000 patients’ data from existing implantable devices will be used to transform care and better meet their needs.
Local authorities developing digital social care projects are to be boosted by more than £1 million in Social Care Digital Innovation Programme (SCDIP) funding, provided by NHS Digital and managed by the Local Government Association (LGA).
Novartis has announced a rise of 5% in net sales in 2018, bringing the net total to $51.9 billion.
NHS England has announced the launch of a new five-year contract for general practice across England, which will see billions of pounds of extra investment for improved access to family doctors, expanded services at local practices and longer appointments for patients who need them.
Parkinson’s UK says it intends to invest a further £1.5 million into its drug discovery programme aiming to develop novel gene transcription modulators for Parkinson’s.
Four groups based at the University of Glasgow are launching a new venture that will offer a ‘one-stop-shop’ for genetic sequencing for clinicians, researchers, industry partners and the NHS.
The Association of the British Pharmaceutical Industry is warning that the UK needs to fill an increasing number of science skills gaps in order to retain its prominent position for medicines and vaccines research and development.
NHS England is planning to recruit and ‘army’ of 1,000 social prescribing ‘link workers’ to help alleviate the growing pressure on family doctors.
The National Institute for Health and Care Excellence and the Ethical Medicines Industry Group (EMIG) are working together to increase understanding of the services the Institute offers the life sciences industry.